StockData
Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc. (OTLK) stock

OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30
$0.36−0.04 (-8.94%)

Close on Nov 17, 2026Market cap $87.79MP/E –Yield –

Outlook Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Outlook Therapeutics's operating margin for the twelve months ending Sep 30, 2019 was -445.6%. For fiscal 2025 it was -4744.3%, against -445.6% the year before. The highest annual figure on record is -445.6% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 2025-4744.3%−4298.7
FY2019Sep 30, 2019-445.6%+514.5
FY2018Sep 30, 2018-960.1%−18.8
FY2017Sep 30, 2017-941.4%+781.9
FY2016Sep 30, 2016-1723.3%−831.2
FY2015Sep 30, 2015-892.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2025CQ2 2025Jun 30, 2025-1046.2%−85.4
Q4 FY2019CQ3 2019Sep 30, 2019-216.8%+1391.4
Q3 FY2019CQ2 2019Jun 30, 2019-966.7%−31.4
Q2 FY2019CQ1 2019Mar 31, 2019-1201.9%−316.9
Q1 FY2019CQ4 2018Dec 31, 2018-960.8%−548.8
Q4 FY2018CQ3 2018Sep 30, 2018-1608.2%−1507.9
Q3 FY2018CQ2 2018Jun 30, 2018-935.4%+1484.8
Q2 FY2018CQ1 2018Mar 31, 2018-885.0%+1700.6
Q1 FY2018CQ4 2017Dec 31, 2017-411.9%+5458.4
Q4 FY2017CQ3 2017Sep 30, 2017-100.3%+1910.7
Q3 FY2017CQ2 2017Jun 30, 2017-2420.1%+2030.8
Q2 FY2017CQ1 2017Mar 31, 2017-2585.6%−2288.7
Q1 FY2017CQ4 2016Dec 31, 2016-5870.3%–
Q4 FY2016CQ3 2016Sep 30, 2016-2011.0%–
Q3 FY2016CQ2 2016Jun 30, 2016-4451.0%–
Q2 FY2016CQ1 2016Mar 31, 2016-296.9%–

More Outlook Therapeutics figures

See a number that looks wrong?